Related Experiment Video
Updated: Aug 16, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Post COVID Vaccination (COVAXIN™ -BB152 V) Pauci-immune Crescentic Glomerulonephritis
Shyam B Bansal1, Abhyuday S Rana1, Neha Manhas1
1Department of Nephrology and Renal Transplant Medicine, Medanta -The Medicity, Gurugram, India.
Insights
COVID-19 vaccination can rarely trigger ANCA-associated vasculitis, leading to kidney damage. This case highlights a potential adverse event following the COVAXIN™ vaccine, emphasizing the need for vigilance.
Area of Science:
- Nephrology
- Immunology
- Vaccinology
Background:
- The COVID-19 pandemic necessitates global vaccination efforts using vaccines like COVAXIN™ (BBV152 V).
- While generally safe, COVID-19 vaccines can rarely be associated with adverse events.
- Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a serious autoimmune condition.
Observation:
- A patient developed pauci-immune crescentic glomerulonephritis 15 days after receiving the second dose of the killed COVID-19 COVAXIN™ vaccine.
- The condition is characterized by ANCA-positive antibodies and kidney inflammation.
Findings:
- The patient's presentation strongly suggests a link between the COVAXIN™ vaccine and the development of ANCA-associated vasculitis (AAV).
- This case indicates that the vaccine may have triggered a systemic immune response leading to rapidly progressive glomerulonephritis (RPGN) in a susceptible individual.
Implications:
- This case underscores the importance of monitoring for rare autoimmune adverse events following COVID-19 vaccination.
- Further research is needed to understand the mechanisms linking vaccines to AAV and to identify susceptible populations.
- Clinicians should consider vaccine-induced AAV in patients presenting with unexplained glomerulonephritis post-vaccination.
Abstract:
Coronavirus disease 2019 (COVID-19) pandemic is responsible for widespread morbidity and mortality. The vaccination against the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection, the cause of the COVID-19 pandemic, is currently ongoing across the globe. Rapid vaccination is of paramount importance to mitigate this pandemic. Although considered safe in general, these vaccines have their share of rare adverse events. We report a case of antineutrophil cytoplasmic antibody (ANCA)-associated pauci-immune crescentic glomerulonephritis 15 days post 2nd dose of a killed COVID-19 (COVAXIN™ -BB152 V) vaccine. We hypothesize that vaccination triggered a systemic immune response in a susceptible patient to develop ANCA-associated vasculitis (AAV), leading to rapidly progressive glomerulonephritis (RPGN).
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Pyelonephritis I: Introduction
Nephrotic Syndrome I : Introduction
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Acute Pyelonephritis II: Diagnostic Studies and Management
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

